Illuminating the biological functions of CDKL1 Kinase
Illuminating the biological functions of CDKL1 Kinase
批准号:
10217716
负责人:
Navjot Pabla
金额:
$15.6万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-04-15 至 2023-03-31
关键词:
AblationAcute Renal Failure with Renal Papillary NecrosisAntibodiesAtlasesBiochemicalBiologicalBiological AssayBiological ProcessBiologyBrainCell Culture TechniquesCell DeathCell physiologyCellsCellular StressClinicalCommunicationCyclic AMP-Dependent Protein KinasesCyclin-Dependent KinasesDependenceDevelopmentDiseaseEnzymesEpithelialEpithelial CellsEtiologyFamilyFamily memberFunctional disorderFutureG-Protein-Coupled ReceptorsGene DeletionGene FamilyGenesGenetic TranscriptionGenomeGoalsHealthHuman GenomeHypoxiaInflammatoryInjuryInjury to KidneyKidneyKnockout MiceLeadLinkMalignant - descriptorMediatingModelingMolecularMolecular TargetMorbidity - disease rateMusNatureNuclearOncogenicPathogenesisPathogenicityPathway interactionsPharmaceutical PreparationsPharmacologyPhosphorylationPhosphotransferasesPhysiologicalPropertyProtein KinaseProtein-Serine-Threonine KinasesProteinsRNA InterferenceRNA interference screenRenal functionResearchRiskRoleSOX11 geneSafetySeveritiesSignal TransductionStressSyndromeTestingTherapeuticTissuesTubular formationbasecancer therapychemical geneticsclinical translationgenetic approachhuman diseasein vivoinnovationinterestkinase inhibitorknock-downmembermortalitymultidisciplinarynephrotoxicitynovelprotein activationrenal epitheliumscreeningsmall moleculetherapeutic targettool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT:
Protein kinases control most cellular processes through signal transduction linked phosphorylation networks.
Importantly, dysregulated protein kinase signaling is both the cause and consequence of numerous human
diseases. Due to the crucial role of kinases in disease pathogenesis, as well as suitable pharmacological
properties and clinical safety profile of kinase inhibitors, protein kinases have emerged as attractive therapeutic
targets, especially for anti-cancer therapy. However, the underlying biology of the majority of protein kinases, a
key gene family within the druggable genome, remains unclear. In addition, the role of protein kinases in the
pathogenesis of non-oncological diseases, especially acute kidney injury (AKI), remains underexplored. AKI is
a common disorder associated with toxic, inflammatory, and hypoxic insults to tubular epithelial cells. Using a
kinome-wide RNAi screen, we recently identified Cdkl5 kinase as a critical regulator of epithelial cell death
associated with acute kidney injury (AKI). While Cdkl5 kinase has been previously studied for its role in brain
development, very little is known about the other four members of the cyclin-dependent kinase-like (Cdkl) family.
Our preliminary results show that Cdkl1 kinase is activated under stress conditions associated with AKI and
RNAi mediated Cdkl1 knockdown protects epithelial cells from nephrotoxic injury. Through chemical genetics
approach, we have also identified Sox11 as a novel Cdkl1 substrate. We hypothesize that Cdkl1 is a stress-
responsive kinase that phosphorylates Sox11 resulting in suppression of a protective transcriptional regulator,
contributing to epithelial dysfunction and cell death. In the current proposal, we aim to test our hypothesis by
examining the consequences of Cdkl1 gene ablation on the severity of AKI (Aim 1) and utilize biochemical and
cell biological approaches to probe the functional consequences of Cdkl1 mediated Sox11 phosphorylation on
stress-induced renal epithelial cell death (Aim 2). These studies will lead to the development of critical
experimental tools that are expected to accelerate future studies into the biological functions of Cdkl1 kinase.
Finally, these studies are expected to reveal the role of Cdkl1 kinase in kidney injury and illuminate the
physiological role of an important member of the enigmatic Cdkl family of kinases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
(9) Therapeutic strategies to mitigate toxicities of platinum-based therapeutics
-
批准号:9303693
-
项目类别:
-
资助金额:$50.33万
-
财政年份:2017
-
负责人:Navjot Pabla
-
依托单位:
(9) Therapeutic strategies to mitigate toxicities of platinum-based therapeutics
-
批准号:9882970
-
项目类别:
-
资助金额:$51.24万
-
财政年份:2017
-
负责人:Navjot Pabla
-
依托单位: